MRK
Merck & Co. Inc.
NYSE
Healthcare
$119.94
+2.36
(+2.00%)
Updated: 3/31/2026, 4:00:01 PM
Open
$119.03
High
$121.25
Low
$117.73
Prev Close
$118.10
Volume
2.90M
Price History
Why Is MRK ▲ Up Today?
+2.00%
Full AI analysis generates after market close. Showing live price data.
Mar 31
▲
+2.0%
MRK Up Slightly Amidst Positive Sector Sentiment
Mar 30
▼
-1.4%
Merck (MRK) dips slightly amid sector gains, acquisition news
Mar 27
▲
+0.6%
Merck (MRK) Up Slightly Amidst Terns Acquisition News
Mar 26
▼
-0.3%
Merck (MRK) Dips Slightly Amid Terns Pharma Acquisition Uncertainty
Mar 25
▲
+2.6%
Merck (MRK) Climbs on Terns Pharma Acquisition
Mar 24
▲
+0.6%
MRK Up Slightly on Positive Sector Sentiment and New Collaboration
Mar 23
▲
+1.3%
MRK Up Slightly Amidst Mixed Sector Performance
Mar 20
—
-0.0%
MRK Dips Slightly Amidst Sector Weakness
Mar 19
▼
-0.3%
Merck (MRK) Down Slightly Amidst Mixed Sector Performance
Mar 18
▼
-1.2%
MRK Down Slightly Amidst Sector Weakness
Mar 17
▲
+0.4%
MRK up slightly despite sector downturn
Mar 16
▼
-0.2%
MRK Down Slightly Amid Mixed Sector Performance
Mar 13
—
-0.1%
MRK dips slightly despite positive sector news
Mar 12
▼
-0.2%
MRK Slight Dip Amidst Positive Analyst Outlook
Mar 11
▼
-0.8%
Merck (MRK) down slightly despite positive sector movement
Mar 10
▼
-0.2%
MRK Down Slightly Amidst Sector Weakness
Mar 9
▲
+1.1%
MRK Up Slightly Amid Positive Clinical Data and Analyst Optimism
Mar 6
▼
-0.6%
Merck (MRK) Down Slightly Amidst Sector Weakness and AI Collaboration News
Mar 5
▼
-3.4%
Merck (MRK) Drops Amidst Market Volatility and Sector Weakness
Mar 4
▲
+0.4%
MRK Up Slightly on AI Deal, Outperforming Sector
Mar 3
▼
-1.8%
MRK Down Slightly Amidst Sector Weakness
Mar 2
▼
-2.2%
Merck (MRK) Down Amidst Sector Weakness and Reorganization Concerns
Feb 27
▲
+3.8%
Merck (MRK) Climbs on Positive Data & Strategic AI Deal
Feb 26
▼
-2.6%
Merck (MRK) Drops Amid Profit Taking Despite Positive News
Feb 25
▼
-1.4%
Merck (MRK) dips slightly despite positive news, lagging sector
Feb 24
—
+0.1%
Merck (MRK) Gains Slightly Amidst Positive Data and Strategic Moves
Feb 23
▲
+1.3%
Merck (MRK) Rises on Strategic Reorganization and Clinical Advancements
Feb 20
▲
+0.3%
MRK Up Slightly Amid Positive Data and AI Deal
Feb 19
▲
+0.6%
Merck (MRK) Up Slightly Amidst Positive Data and AI Collaboration
Feb 18
▲
+0.4%
Merck (MRK) Up Slightly Despite Sector Weakness
Financial Highlights
Income Statement
Revenue
$64.23B
Gross Profit
$49.58B
77.2% margin
Operating Income
$21.82B
34.0% margin
Net Income
$19.04B
29.6% margin
EPS (Diluted)
$7.57
R&D Spend
$16.49B
Balance Sheet
Total Assets
$129.55B
Total Liabilities
$77.64B
Stockholders' Equity
$51.91B
Cash Flow
Operating Cash Flow
$17.07B
Investing Activities
-$3.98B
Net Cash Flow
$3.57B
Highly Regarded Analysis for MRK
Get a deep-dive analysis including bull/bear cases, technical outlook, price targets, and key catalysts — powered by Highly Regarded's proprietary analysis engine.
Usually takes 10-20 seconds
Analyzing MRK...
Searching financial data and generating insights
Analysis couldn't be generated
Key Stats
P/E Ratio
15.8x
EPS (Diluted)
$7.57
Gross Margin
77.2%
Operating Margin
34.0%
Net Margin
29.6%
Revenue (Qtr)
$64.23B
Shares Outstanding
2.48B
Next Earnings
Date
Aug 4, 2026
Time
Before Open
Quarter
Q2 2026
EPS Estimate
$2.11
MRK News
No recent news for MRK.